Citius Oncology, Inc. (CTOR) earnings
CTOR earnings moved a median of -3.28% by the close. Quarterly and annual CTOR reports and results, each read against the price at its own news timestamp. Back to the CTOR overview →
14 measured CTOR earnings events.
Where these CTOR earnings landedvs 14 measured CTOR earnings reactions
| Middle 50% of CTOR earnings reactions | -4.12% to +0.54% |
|---|---|
| Median reaction (to close) | -3.28% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 CTOR earnings events with a measured close landed between -4.12% and +0.54%; 29% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update | Press release | -2.55% | -4.12% | |
| Form 10-Q CITIUS ONCOLOGY, INC. For: Jun 30 | SEC filing · Form 10-Q | -2.55% | -4.12% | |
| Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update | Press release | -4.50% | -5.27% | |
| Form 10-Q CITIUS ONCOLOGY, INC. For: Mar 31 | SEC filing · Form 10-Q | -4.50% | -5.27% | |
| Form 10-Q CITIUS ONCOLOGY, INC. For: Dec 31 | SEC filing · Form 10-Q | -1.88% | +1.67% | |
| Form 10-K CITIUS ONCOLOGY, INC. For: Sep 30 | SEC filing · Form 10-K | +4.07% | -6.91% | |
| Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update | Press release | +0.54% | +5.29% | |
| Form 10-Q CITIUS ONCOLOGY, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.54% | +5.29% | |
| Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | -2.84% | |
| Form 10-Q CITIUS ONCOLOGY, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.84% | |
| Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | -3.28% | |
| Form 10-Q CITIUS ONCOLOGY, INC. For: Dec 31 | SEC filing · Form 10-Q | +0.00% | -3.28% | |
| Form 10-K/A CITIUS ONCOLOGY, INC. For: Sep 30 | SEC filing · Form 10-K | +0.00% | +2.08% | |
| Form 10-K CITIUS ONCOLOGY, INC. For: Sep 30 | SEC filing · Form 10-K | -2.15% | -3.45% |
Keep exploring
More CTOR: analyst actions → · SEC filings → · CTOR overview →